Get the Stockscreener App
3.395
0.15%
0.005
Envveno Medical Corporation stock is traded at $3.395, with a volume of 42,601.
It is up +0.15% in the last 24 hours and up +5.11% over the past month.
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
See More
Previous Close:
$3.39
Open:
$3.39
24h Volume:
42,601
Relative Volume:
0.36
Market Cap:
$59.45M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-1.5156
EPS:
-2.24
Net Cash Flow:
$-17.78M
1W Performance:
-1.59%
1M Performance:
+5.11%
6M Performance:
-32.77%
1Y Performance:
-17.60%
1-Day Range:
$3.3448
$3.43
1-Week Range:
$3.245
$3.47
52-Week Range:
$3.012
$6.97
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Envveno Medical Corporation Stock (NVNO) Latest News
enVVeno Medical (FRA:5HJ) Cyclically Adjusted FCF per Share : €0.00 (As of Jun. 2024) - GuruFocus.com
enVVeno Medical expects capital to fund company through several milestones - TipRanks
enVVeno Medical reports Q3 EPS (35c) vs. (45c) last year - TipRanks
enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year - AccessWire
EnVVeno Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
enVVeno Medical initiates six-month pre-clinical GLP study of enVVe - TipRanks
enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R) - AccessWire
Comparing enVVeno Medical (NASDAQ:NVNO) and Accuray (NASDAQ:ARAY) - Defense World
NVNO Stock Hits 52-Week Low at $3.06 Amid Market Challenges - Investing.com UK
Contrasting enVVeno Medical (NASDAQ:NVNO) and Lucid Diagnostics (NASDAQ:LUCD) - Defense World
Do investors need to be concerned about enVVeno Medical Corporation (NVNO)? - US Post News
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session - MSN
NVNO: A Tale of Ups & Downs – -40.44% loss in 6 Months, -38.98% in 30 Days - The InvestChronicle
Market Resilience: enVVeno Medical Corporation (NVNO) Finishes Weak at 3.24, Down -28.00 - The Dwinnex
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.33% - MSN
NVNO stock touches 52-week low at $3.4 amid market challenges - Investing.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.33% - MSN
enVVeno Medical stock falls after it prices $15M securities offering - MSN
NVNOenVVeno Medical Corporation Latest Stock News & Market Updates - StockTitan
EnVVeno Medical Announces Pricing Of Public OfferingQuick Facts - Nasdaq
Costco, Scholastic And 3 Stocks To Watch Heading Into Friday - Benzinga
enVVeno Medical launches public stock offering By Investing.com - Investing.com Australia
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering - StockTitan
enVVeno Medical launches public stock offering - Investing.com India
enVVeno Medical offers to sell common stock - MSN
enVVeno Medical Corporation Announces Proposed Public Offering - AccessWire
Evolv Technologies (NASDAQ:EVLV) Shares Down 2.9% - Defense World
EverSource Wealth Advisors LLC Raises Stock Position in Elevance Health, Inc. (NYSE:ELV) - Defense World
Enliven Therapeutics (NASDAQ:ELVN) Shares Gap Down to $23.57 - MarketBeat
Logos Global Management LP Lowers Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
First Light Asset Management LLC Has $27.63 Million Stake in Evolent Health, Inc. (NYSE:EVH) - Defense World
Elevance Health Inc [ELV] PERU RAMIRO G sells 753 Shares for $0.4 million - Knox Daily
Evolv Technologies Holdings Inc (EVLV) looking to reclaim success with recent performance - SETE News
Check out these key findings about Elevation Oncology Inc (ELEV) - SETE News
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt - Simply Wall St
Gabelli Funds LLC Buys 93,500 Shares of Evolent Health, Inc. (NYSE:EVH) - Defense World
Evolution AB: This Bargain-Priced Compounder Has Massive Upside Potential (OTCMKTS:EVVTY) - Seeking Alpha
Vanguard Personalized Indexing Management LLC Buys 864 Shares of Everest Group, Ltd. (NYSE:EG) - Defense World
Enlivex Announces Positive DSMB Recommendation to Initiate - GlobeNewswire
Lombard Odier Asset Management Europe Ltd Invests $2.51 Million in Elevance Health, Inc. (NYSE:ELV) - Defense World
Distillate Capital Partners LLC Grows Position in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Vanguard Personalized Indexing Management LLC Has $924,000 Stake in Entegris, Inc. (NASDAQ:ENTG) - Defense World
Victory Capital Management Inc. Sells 414,447 Shares of Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Elevance Health, Inc. (NYSE:ELV) Position Boosted by Magnetar Financial LLC - Defense World
Prepare Yourself for Liftoff: Enova International Inc. (ENVA) - SETE News
Perhaps timely catching Enliven Therapeutics Inc (ELVN) would be a good idea - SETE News
Ratios in Focus: Analyzing Elevation Oncology Inc (ELEV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Investing in Elevation Oncology Inc (ELEV) might be a great opportunity, but the stock is a bit undervalued - US Post News
Ensign Peak Advisors Inc Acquires 2,862 Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
How should investors view Evolv Technologies Holdings Inc (EVLV)? - US Post News
Evexia Lifecare shares gain as company approves funds raise via convertible warrants - India.com
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):